Russell Silver syndrome: a perspective on growth and the influence of growth hormone therapy

J V Mascarenhas1, Vageesh S Ayyar

  • 1Department of Endocrinology, St. John's Medical College, Bangalore, India.

Insights

Russell Silver Syndrome (RSS) in a child with failure to thrive was diagnosed with growth hormone deficiency. Recombinant human growth hormone (rhGH) therapy significantly improved height, demonstrating its efficacy.

Area of Science:

  • Pediatric Endocrinology
  • Genetics and Rare Diseases

Background:

  • Russell Silver Syndrome (RSS) is a rare genetic disorder characterized by intrauterine and postnatal growth retardation.
  • Patients often present with failure to thrive, short stature, and distinct facial features.

Observation:

  • A 6-year-old male with RSS presented with failure to thrive, short stature, relative macrocephaly, triangular facies, and clinodactyly.
  • Hormonal analysis revealed low Insulin-like Growth Factor 1 (IGF-1) and basal Growth Hormone (GH) levels.
  • A clonidine stimulation test confirmed complete GH deficiency.

Findings:

  • The patient was initiated on recombinant human GH (rhGH) therapy at 8 years old due to financial constraints.
  • After 19 months of rhGH treatment (1.5 IU/day), a height gain of 15 cm was achieved.
  • Bone age assessment indicated a delay, with the bone age at 9 years being between 7-8 years.

Implications:

  • This case highlights the effectiveness of rhGH therapy in improving linear growth in children with RSS and GH deficiency.
  • Early diagnosis and timely intervention with GH therapy are crucial for optimizing outcomes in RSS patients.
  • Addressing financial barriers is essential for consistent and effective treatment adherence in pediatric endocrine disorders.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Growth versus Fixed Mindset01:24

Growth versus Fixed Mindset

Carol Dweck introduced the term mindset to describe individuals' beliefs about their intellectual and personal capabilities. These beliefs significantly influence psychological processes such as motivation, goal-setting, and perseverance, ultimately shaping academic and life outcomes. Individuals generally possess one of two mindsets- a fixed or a growth mindset—each promoting different responses to success, failure, and challenge.Fixed vs. Growth MindsetA fixed mindset assumes that one's...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...